nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—Interstitial lung disease—Sorafenib—liver cancer	0.0264	0.0313	CcSEcCtD
Desvenlafaxine—Myocardial ischaemia—Sorafenib—liver cancer	0.0232	0.0276	CcSEcCtD
Desvenlafaxine—Proteinuria—Sorafenib—liver cancer	0.0213	0.0252	CcSEcCtD
Desvenlafaxine—Protein urine present—Sorafenib—liver cancer	0.021	0.0249	CcSEcCtD
Desvenlafaxine—Bone disorder—Sorafenib—liver cancer	0.0207	0.0245	CcSEcCtD
Desvenlafaxine—Blood pressure increased—Sorafenib—liver cancer	0.0187	0.0222	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Sorafenib—liver cancer	0.0136	0.0162	CcSEcCtD
Desvenlafaxine—Breast disorder—Sorafenib—liver cancer	0.0123	0.0145	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.0122	0.0145	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Sorafenib—liver cancer	0.0108	0.0128	CcSEcCtD
Desvenlafaxine—Weight decreased—Sorafenib—liver cancer	0.0106	0.0126	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.0104	0.0123	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Sorafenib—liver cancer	0.0103	0.0122	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Sorafenib—liver cancer	0.0102	0.0122	CcSEcCtD
Desvenlafaxine—Epistaxis—Sorafenib—liver cancer	0.00986	0.0117	CcSEcCtD
Desvenlafaxine—CYP3A4—Felbamate Metabolism—CYP2E1—liver cancer	0.00976	0.0621	CbGpPWpGaD
Desvenlafaxine—Urinary tract disorder—Sorafenib—liver cancer	0.00926	0.011	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Sorafenib—liver cancer	0.00922	0.0109	CcSEcCtD
Desvenlafaxine—Urethral disorder—Sorafenib—liver cancer	0.0092	0.0109	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Sorafenib—liver cancer	0.00887	0.0105	CcSEcCtD
Desvenlafaxine—Tinnitus—Sorafenib—liver cancer	0.00875	0.0104	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Sorafenib—liver cancer	0.00871	0.0103	CcSEcCtD
Desvenlafaxine—Angiopathy—Sorafenib—liver cancer	0.00851	0.0101	CcSEcCtD
Desvenlafaxine—Immune system disorder—Sorafenib—liver cancer	0.00847	0.0101	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Sorafenib—liver cancer	0.00846	0.01	CcSEcCtD
Desvenlafaxine—Alopecia—Sorafenib—liver cancer	0.00829	0.00984	CcSEcCtD
Desvenlafaxine—Mental disorder—Sorafenib—liver cancer	0.00822	0.00975	CcSEcCtD
Desvenlafaxine—Malnutrition—Sorafenib—liver cancer	0.00817	0.00969	CcSEcCtD
Desvenlafaxine—Dysgeusia—Sorafenib—liver cancer	0.008	0.00949	CcSEcCtD
Desvenlafaxine—Bone disorder—Epirubicin—liver cancer	0.00764	0.00907	CcSEcCtD
Desvenlafaxine—Angioedema—Sorafenib—liver cancer	0.00746	0.00885	CcSEcCtD
Desvenlafaxine—Syncope—Sorafenib—liver cancer	0.00732	0.00869	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Sorafenib—liver cancer	0.00718	0.00852	CcSEcCtD
Desvenlafaxine—Bone disorder—Doxorubicin—liver cancer	0.00707	0.00839	CcSEcCtD
Desvenlafaxine—Hypertension—Sorafenib—liver cancer	0.00705	0.00837	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.0069	0.00819	CcSEcCtD
Desvenlafaxine—Abnormal dreams—Epirubicin—liver cancer	0.00682	0.0081	CcSEcCtD
Desvenlafaxine—Dry mouth—Sorafenib—liver cancer	0.0068	0.00807	CcSEcCtD
Desvenlafaxine—Shock—Sorafenib—liver cancer	0.00656	0.00778	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Sorafenib—liver cancer	0.00654	0.00776	CcSEcCtD
Desvenlafaxine—Skin disorder—Sorafenib—liver cancer	0.00647	0.00768	CcSEcCtD
Desvenlafaxine—Abnormal dreams—Doxorubicin—liver cancer	0.00631	0.00749	CcSEcCtD
Desvenlafaxine—CYP3A4—Liver X Receptor Pathway—SCD—liver cancer	0.00586	0.0373	CbGpPWpGaD
Desvenlafaxine—Decreased appetite—Sorafenib—liver cancer	0.00579	0.00687	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00575	0.00683	CcSEcCtD
Desvenlafaxine—Fatigue—Sorafenib—liver cancer	0.00575	0.00682	CcSEcCtD
Desvenlafaxine—Constipation—Sorafenib—liver cancer	0.0057	0.00676	CcSEcCtD
Desvenlafaxine—Hot flush—Epirubicin—liver cancer	0.00536	0.00636	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Epirubicin—liver cancer	0.00531	0.0063	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Epirubicin—liver cancer	0.00503	0.00597	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00501	0.00595	CcSEcCtD
Desvenlafaxine—Hot flush—Doxorubicin—liver cancer	0.00496	0.00588	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Doxorubicin—liver cancer	0.00491	0.00583	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Sorafenib—liver cancer	0.00491	0.00583	CcSEcCtD
Desvenlafaxine—Asthenia—Sorafenib—liver cancer	0.00478	0.00567	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Doxorubicin—liver cancer	0.00466	0.00552	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00464	0.0055	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Epirubicin—liver cancer	0.00463	0.00549	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Epirubicin—liver cancer	0.00458	0.00543	CcSEcCtD
Desvenlafaxine—Diarrhoea—Sorafenib—liver cancer	0.00456	0.00541	CcSEcCtD
Desvenlafaxine—Breast disorder—Epirubicin—liver cancer	0.00453	0.00537	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00451	0.00535	CcSEcCtD
Desvenlafaxine—Dizziness—Sorafenib—liver cancer	0.00441	0.00523	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Doxorubicin—liver cancer	0.00428	0.00508	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—DNAJB1—liver cancer	0.00425	0.027	CbGpPWpGaD
Desvenlafaxine—Vomiting—Sorafenib—liver cancer	0.00424	0.00503	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Doxorubicin—liver cancer	0.00424	0.00503	CcSEcCtD
Desvenlafaxine—Rash—Sorafenib—liver cancer	0.0042	0.00499	CcSEcCtD
Desvenlafaxine—Dermatitis—Sorafenib—liver cancer	0.0042	0.00498	CcSEcCtD
Desvenlafaxine—Breast disorder—Doxorubicin—liver cancer	0.00419	0.00497	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00418	0.00495	CcSEcCtD
Desvenlafaxine—Headache—Sorafenib—liver cancer	0.00418	0.00495	CcSEcCtD
Desvenlafaxine—Nausea—Sorafenib—liver cancer	0.00396	0.0047	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Epirubicin—liver cancer	0.00395	0.00469	CcSEcCtD
Desvenlafaxine—Weight increased—Epirubicin—liver cancer	0.00394	0.00468	CcSEcCtD
Desvenlafaxine—Weight decreased—Epirubicin—liver cancer	0.00392	0.00465	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—SIX3—liver cancer	0.00387	0.0246	CbGpPWpGaD
Desvenlafaxine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00383	0.00454	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Doxorubicin—liver cancer	0.00366	0.00434	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—DNAJB1—liver cancer	0.00365	0.0232	CbGpPWpGaD
Desvenlafaxine—Weight increased—Doxorubicin—liver cancer	0.00365	0.00433	CcSEcCtD
Desvenlafaxine—Epistaxis—Epirubicin—liver cancer	0.00364	0.00432	CcSEcCtD
Desvenlafaxine—Weight decreased—Doxorubicin—liver cancer	0.00363	0.0043	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00354	0.0042	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Epirubicin—liver cancer	0.00342	0.00406	CcSEcCtD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00342	0.0218	CbGpPWpGaD
Desvenlafaxine—Connective tissue disorder—Epirubicin—liver cancer	0.00341	0.00404	CcSEcCtD
Desvenlafaxine—Urethral disorder—Epirubicin—liver cancer	0.0034	0.00403	CcSEcCtD
Desvenlafaxine—Epistaxis—Doxorubicin—liver cancer	0.00337	0.004	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Epirubicin—liver cancer	0.00328	0.00389	CcSEcCtD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00326	0.0208	CbGpPWpGaD
Desvenlafaxine—Eye disorder—Epirubicin—liver cancer	0.00324	0.00384	CcSEcCtD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.00323	0.0206	CbGpPWpGaD
Desvenlafaxine—Tinnitus—Epirubicin—liver cancer	0.00323	0.00384	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Epirubicin—liver cancer	0.00322	0.00382	CcSEcCtD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00318	0.0202	CbGpPWpGaD
Desvenlafaxine—Urinary tract disorder—Doxorubicin—liver cancer	0.00317	0.00376	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Doxorubicin—liver cancer	0.00315	0.00374	CcSEcCtD
Desvenlafaxine—Angiopathy—Epirubicin—liver cancer	0.00315	0.00373	CcSEcCtD
Desvenlafaxine—Urethral disorder—Doxorubicin—liver cancer	0.00314	0.00373	CcSEcCtD
Desvenlafaxine—Immune system disorder—Epirubicin—liver cancer	0.00313	0.00372	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Epirubicin—liver cancer	0.00312	0.00371	CcSEcCtD
Desvenlafaxine—Chills—Epirubicin—liver cancer	0.00311	0.00369	CcSEcCtD
Desvenlafaxine—Alopecia—Epirubicin—liver cancer	0.00306	0.00364	CcSEcCtD
Desvenlafaxine—Mental disorder—Epirubicin—liver cancer	0.00304	0.0036	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Doxorubicin—liver cancer	0.00303	0.0036	CcSEcCtD
Desvenlafaxine—Malnutrition—Epirubicin—liver cancer	0.00302	0.00358	CcSEcCtD
Desvenlafaxine—Eye disorder—Doxorubicin—liver cancer	0.003	0.00356	CcSEcCtD
Desvenlafaxine—Tinnitus—Doxorubicin—liver cancer	0.00299	0.00355	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Doxorubicin—liver cancer	0.00298	0.00353	CcSEcCtD
Desvenlafaxine—Tension—Epirubicin—liver cancer	0.00296	0.00351	CcSEcCtD
Desvenlafaxine—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.00296	0.0188	CbGpPWpGaD
Desvenlafaxine—Dysgeusia—Epirubicin—liver cancer	0.00296	0.00351	CcSEcCtD
Desvenlafaxine—Nervousness—Epirubicin—liver cancer	0.00293	0.00348	CcSEcCtD
Desvenlafaxine—Angiopathy—Doxorubicin—liver cancer	0.00291	0.00345	CcSEcCtD
Desvenlafaxine—Immune system disorder—Doxorubicin—liver cancer	0.0029	0.00344	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Doxorubicin—liver cancer	0.00289	0.00343	CcSEcCtD
Desvenlafaxine—Chills—Doxorubicin—liver cancer	0.00288	0.00342	CcSEcCtD
Desvenlafaxine—Vision blurred—Epirubicin—liver cancer	0.00284	0.00337	CcSEcCtD
Desvenlafaxine—Alopecia—Doxorubicin—liver cancer	0.00283	0.00336	CcSEcCtD
Desvenlafaxine—Mental disorder—Doxorubicin—liver cancer	0.00281	0.00333	CcSEcCtD
Desvenlafaxine—Malnutrition—Doxorubicin—liver cancer	0.00279	0.00331	CcSEcCtD
Desvenlafaxine—SLC6A4—Monoamine Transport—MAPK14—liver cancer	0.00276	0.0176	CbGpPWpGaD
Desvenlafaxine—Tension—Doxorubicin—liver cancer	0.00274	0.00325	CcSEcCtD
Desvenlafaxine—Dysgeusia—Doxorubicin—liver cancer	0.00273	0.00324	CcSEcCtD
Desvenlafaxine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00271	0.0173	CbGpPWpGaD
Desvenlafaxine—Nervousness—Doxorubicin—liver cancer	0.00271	0.00322	CcSEcCtD
Desvenlafaxine—Vertigo—Epirubicin—liver cancer	0.00271	0.00322	CcSEcCtD
Desvenlafaxine—Syncope—Epirubicin—liver cancer	0.00271	0.00321	CcSEcCtD
Desvenlafaxine—Palpitations—Epirubicin—liver cancer	0.00267	0.00316	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Epirubicin—liver cancer	0.00265	0.00315	CcSEcCtD
Desvenlafaxine—Vision blurred—Doxorubicin—liver cancer	0.00263	0.00312	CcSEcCtD
Desvenlafaxine—Convulsion—Epirubicin—liver cancer	0.00262	0.0031	CcSEcCtD
Desvenlafaxine—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.00261	0.0166	CbGpPWpGaD
Desvenlafaxine—Hypertension—Epirubicin—liver cancer	0.00261	0.00309	CcSEcCtD
Desvenlafaxine—Anxiety—Epirubicin—liver cancer	0.00256	0.00304	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00255	0.00303	CcSEcCtD
Desvenlafaxine—Dry mouth—Epirubicin—liver cancer	0.00251	0.00298	CcSEcCtD
Desvenlafaxine—Vertigo—Doxorubicin—liver cancer	0.00251	0.00298	CcSEcCtD
Desvenlafaxine—Syncope—Doxorubicin—liver cancer	0.0025	0.00297	CcSEcCtD
Desvenlafaxine—Palpitations—Doxorubicin—liver cancer	0.00247	0.00293	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Doxorubicin—liver cancer	0.00245	0.00291	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTA3—liver cancer	0.00244	0.0155	CbGpPWpGaD
Desvenlafaxine—Shock—Epirubicin—liver cancer	0.00242	0.00288	CcSEcCtD
Desvenlafaxine—Convulsion—Doxorubicin—liver cancer	0.00242	0.00287	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Epirubicin—liver cancer	0.00242	0.00287	CcSEcCtD
Desvenlafaxine—Hypertension—Doxorubicin—liver cancer	0.00241	0.00286	CcSEcCtD
Desvenlafaxine—Tachycardia—Epirubicin—liver cancer	0.0024	0.00285	CcSEcCtD
Desvenlafaxine—Skin disorder—Epirubicin—liver cancer	0.00239	0.00284	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Epirubicin—liver cancer	0.00238	0.00283	CcSEcCtD
Desvenlafaxine—SLC6A2—Monoamine Transport—MAPK14—liver cancer	0.00238	0.0151	CbGpPWpGaD
Desvenlafaxine—Anxiety—Doxorubicin—liver cancer	0.00237	0.00281	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00236	0.0028	CcSEcCtD
Desvenlafaxine—Dry mouth—Doxorubicin—liver cancer	0.00233	0.00276	CcSEcCtD
Desvenlafaxine—Shock—Doxorubicin—liver cancer	0.00224	0.00266	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Doxorubicin—liver cancer	0.00224	0.00265	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTA4—liver cancer	0.00223	0.0142	CbGpPWpGaD
Desvenlafaxine—Insomnia—Epirubicin—liver cancer	0.00223	0.00264	CcSEcCtD
Desvenlafaxine—Tachycardia—Doxorubicin—liver cancer	0.00222	0.00264	CcSEcCtD
Desvenlafaxine—Skin disorder—Doxorubicin—liver cancer	0.00221	0.00263	CcSEcCtD
Desvenlafaxine—Paraesthesia—Epirubicin—liver cancer	0.00221	0.00262	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Doxorubicin—liver cancer	0.0022	0.00261	CcSEcCtD
Desvenlafaxine—Somnolence—Epirubicin—liver cancer	0.00219	0.0026	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTA2—liver cancer	0.00217	0.0138	CbGpPWpGaD
Desvenlafaxine—Decreased appetite—Epirubicin—liver cancer	0.00214	0.00254	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00213	0.00252	CcSEcCtD
Desvenlafaxine—Fatigue—Epirubicin—liver cancer	0.00212	0.00252	CcSEcCtD
Desvenlafaxine—Constipation—Epirubicin—liver cancer	0.00211	0.0025	CcSEcCtD
Desvenlafaxine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.0021	0.0134	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTA1—liver cancer	0.0021	0.0133	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTA3—liver cancer	0.0021	0.0133	CbGpPWpGaD
Desvenlafaxine—Insomnia—Doxorubicin—liver cancer	0.00206	0.00245	CcSEcCtD
Desvenlafaxine—Paraesthesia—Doxorubicin—liver cancer	0.00205	0.00243	CcSEcCtD
Desvenlafaxine—Somnolence—Doxorubicin—liver cancer	0.00203	0.0024	CcSEcCtD
Desvenlafaxine—Decreased appetite—Doxorubicin—liver cancer	0.00198	0.00235	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00197	0.00233	CcSEcCtD
Desvenlafaxine—Fatigue—Doxorubicin—liver cancer	0.00196	0.00233	CcSEcCtD
Desvenlafaxine—Constipation—Doxorubicin—liver cancer	0.00195	0.00231	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTA4—liver cancer	0.00192	0.0122	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00192	0.0122	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTA2—liver cancer	0.00187	0.0119	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00186	0.0118	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00185	0.0118	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—NFE2L2—liver cancer	0.00185	0.0118	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00183	0.0116	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Epirubicin—liver cancer	0.00181	0.00215	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTA1—liver cancer	0.0018	0.0115	CbGpPWpGaD
Desvenlafaxine—Asthenia—Epirubicin—liver cancer	0.00177	0.0021	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—GPX3—liver cancer	0.00176	0.0112	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFA—liver cancer	0.00176	0.0112	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—SERPINA1—liver cancer	0.00174	0.0111	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.00171	0.0109	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Epirubicin—liver cancer	0.00169	0.002	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Doxorubicin—liver cancer	0.00168	0.00199	CcSEcCtD
Desvenlafaxine—Asthenia—Doxorubicin—liver cancer	0.00164	0.00194	CcSEcCtD
Desvenlafaxine—Dizziness—Epirubicin—liver cancer	0.00163	0.00193	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—NFE2L2—liver cancer	0.00159	0.0101	CbGpPWpGaD
Desvenlafaxine—Vomiting—Epirubicin—liver cancer	0.00157	0.00186	CcSEcCtD
Desvenlafaxine—Diarrhoea—Doxorubicin—liver cancer	0.00156	0.00185	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00155	0.00989	CbGpPWpGaD
Desvenlafaxine—Rash—Epirubicin—liver cancer	0.00155	0.00184	CcSEcCtD
Desvenlafaxine—Dermatitis—Epirubicin—liver cancer	0.00155	0.00184	CcSEcCtD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00155	0.00984	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00154	0.00982	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00154	0.00982	CbGpPWpGaD
Desvenlafaxine—Headache—Epirubicin—liver cancer	0.00154	0.00183	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFA—liver cancer	0.00152	0.00965	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GPX3—liver cancer	0.00152	0.00965	CbGpPWpGaD
Desvenlafaxine—Dizziness—Doxorubicin—liver cancer	0.00151	0.00179	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—SERPINA1—liver cancer	0.00149	0.00951	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.00149	0.00946	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00148	0.00943	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00148	0.00941	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—AHR—liver cancer	0.00147	0.00934	CbGpPWpGaD
Desvenlafaxine—Nausea—Epirubicin—liver cancer	0.00146	0.00174	CcSEcCtD
Desvenlafaxine—Vomiting—Doxorubicin—liver cancer	0.00145	0.00172	CcSEcCtD
Desvenlafaxine—Rash—Doxorubicin—liver cancer	0.00144	0.00171	CcSEcCtD
Desvenlafaxine—Dermatitis—Doxorubicin—liver cancer	0.00144	0.0017	CcSEcCtD
Desvenlafaxine—Headache—Doxorubicin—liver cancer	0.00143	0.00169	CcSEcCtD
Desvenlafaxine—Nausea—Doxorubicin—liver cancer	0.00135	0.00161	CcSEcCtD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00133	0.00845	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—TNF—liver cancer	0.00131	0.00835	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00128	0.00811	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GGT1—liver cancer	0.00124	0.00789	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.00121	0.00769	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00118	0.0075	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.00116	0.00737	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—TNF—liver cancer	0.00113	0.00718	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTP1—liver cancer	0.00111	0.00709	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.00111	0.00707	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HMOX1—liver cancer	0.0011	0.00699	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.00107	0.0068	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GGT1—liver cancer	0.00107	0.00679	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HGF—liver cancer	0.00102	0.00652	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTM1—liver cancer	0.00102	0.00652	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00101	0.00644	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTP1—liver cancer	0.000958	0.0061	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000956	0.00608	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—HMOX1—liver cancer	0.000945	0.00601	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—HGF—liver cancer	0.000881	0.0056	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTM1—liver cancer	0.000881	0.0056	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000869	0.00553	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000794	0.00505	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00079	0.00503	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000754	0.00479	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000723	0.0046	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000723	0.0046	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PPARA—liver cancer	0.000688	0.00437	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000683	0.00435	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000665	0.00423	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000642	0.00409	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000634	0.00403	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000571	0.00363	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PPARG—liver cancer	0.000568	0.00362	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000549	0.0035	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000521	0.00331	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—SERPINE1—liver cancer	0.000512	0.00326	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000508	0.00323	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000508	0.00323	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000499	0.00318	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—JUN—liver cancer	0.000494	0.00314	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000492	0.00313	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.00049	0.00312	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000461	0.00294	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000456	0.0029	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000455	0.0029	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.00045	0.00286	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000445	0.00283	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000431	0.00274	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000429	0.00273	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000424	0.0027	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000419	0.00266	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFB1—liver cancer	0.000417	0.00266	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—JUN—liver cancer	0.000403	0.00256	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—MAPK8—liver cancer	0.000381	0.00243	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000374	0.00238	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—liver cancer	0.00037	0.00235	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFB1—liver cancer	0.000359	0.00228	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—ALB—liver cancer	0.000358	0.00228	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000356	0.00226	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000348	0.00222	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000339	0.00216	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000303	0.00193	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—liver cancer	0.000298	0.0019	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000277	0.00176	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000273	0.00174	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TP53—liver cancer	0.000266	0.00169	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000254	0.00162	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000245	0.00156	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—IL6—liver cancer	0.000244	0.00155	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000228	0.00145	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000225	0.00143	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.00021	0.00133	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000207	0.00132	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000199	0.00126	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000196	0.00125	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ALB—liver cancer	0.000182	0.00116	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000164	0.00105	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—UGDH—liver cancer	0.000149	0.000945	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—EPT1—liver cancer	0.00014	0.000889	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—TAT—liver cancer	0.000132	0.000843	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CPT1B—liver cancer	9e-05	0.000573	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GLUL—liver cancer	9e-05	0.000573	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NR1H4—liver cancer	8.68e-05	0.000552	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA3—liver cancer	8.54e-05	0.000543	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA4—liver cancer	7.81e-05	0.000497	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA2—liver cancer	7.61e-05	0.000484	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA1—liver cancer	7.34e-05	0.000467	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NAT2—liver cancer	7.26e-05	0.000462	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALDOB—liver cancer	6.96e-05	0.000443	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CRABP1—liver cancer	6.64e-05	0.000422	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HPGDS—liver cancer	5.8e-05	0.000369	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PSMA4—liver cancer	5.17e-05	0.000329	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PSMD10—liver cancer	5.17e-05	0.000329	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GOT2—liver cancer	5.03e-05	0.00032	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP2E1—liver cancer	4.73e-05	0.000301	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYCS—liver cancer	4.43e-05	0.000282	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GOT1—liver cancer	4.34e-05	0.000276	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GGT1—liver cancer	4.34e-05	0.000276	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTP1—liver cancer	3.9e-05	0.000248	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMOX1—liver cancer	3.85e-05	0.000245	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTM1—liver cancer	3.58e-05	0.000228	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP1A1—liver cancer	3.4e-05	0.000216	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MTHFR—liver cancer	3.17e-05	0.000202	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPARA—liver cancer	3.11e-05	0.000198	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CG—liver cancer	2.66e-05	0.000169	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPARG—liver cancer	2.57e-05	0.000163	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CD—liver cancer	2.34e-05	0.000149	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALB—liver cancer	2.31e-05	0.000147	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CB—liver cancer	2.04e-05	0.00013	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.24e-05	7.91e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AKT1—liver cancer	1.02e-05	6.46e-05	CbGpPWpGaD
